scholarly journals Efficacy of Ebola Glycoprotein-Specific Equine Polyclonal Antibody Product Against Lethal Ebola Virus Infection in Guinea Pigs

2018 ◽  
Vol 218 (suppl_5) ◽  
pp. S603-S611 ◽  
Author(s):  
Mable Chan ◽  
Frederick W Holtsberg ◽  
Hong Vu ◽  
Katie A Howell ◽  
Anders Leung ◽  
...  
1999 ◽  
Vol 179 (s1) ◽  
pp. S203-S217 ◽  
Author(s):  
Brett M. Connolly ◽  
Keith E. Steele ◽  
Kelly J. Davis ◽  
Thomas W. Geisbert ◽  
Wayne M. Kell ◽  
...  

1996 ◽  
Vol 141 (5) ◽  
pp. 909-921 ◽  
Author(s):  
E. Ryabchikova ◽  
L. Kolesnikova ◽  
M. Smolina ◽  
V. Tkachev ◽  
L. Pereboeva ◽  
...  

2015 ◽  
Vol 213 (7) ◽  
pp. 1124-1133 ◽  
Author(s):  
Stuart David Dowall ◽  
Jo Callan ◽  
Antra Zeltina ◽  
Ibrahim Al-Abdulla ◽  
Thomas Strecker ◽  
...  

2012 ◽  
Vol 6 (3) ◽  
pp. e1575 ◽  
Author(s):  
Xiangguo Qiu ◽  
Lisa Fernando ◽  
P. Leno Melito ◽  
Jonathan Audet ◽  
Heinz Feldmann ◽  
...  

2003 ◽  
Vol 77 (13) ◽  
pp. 7539-7544 ◽  
Author(s):  
Ayato Takada ◽  
Heinz Feldmann ◽  
Thomas G. Ksiazek ◽  
Yoshihiro Kawaoka

ABSTRACT Most strains of Ebola virus cause a rapidly fatal hemorrhagic disease in humans, yet there are still no biologic explanations that adequately account for the extreme virulence of these emerging pathogens. Here we show that Ebola Zaire virus infection in humans induces antibodies that enhance viral infectivity. Plasma or serum from convalescing patients enhanced the infection of primate kidney cells by the Zaire virus, and this enhancement was mediated by antibodies to the viral glycoprotein and by complement component C1q. Our results suggest a novel mechanism of antibody-dependent enhancement of Ebola virus infection, one that would account for the dire outcome of Ebola outbreaks in human populations.


Sign in / Sign up

Export Citation Format

Share Document